The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ventriculoperitoneal (VP) Shunt-Global Market Insights and Sales Trends 2024
Synopsis
An implanted shunt diverts CSF from the ventricles within the brain or the subarachnoid spaces around the brain and spinal cord to another body region where it will be absorbed. This creates an alternative route for removal of CSF which is constantly produced within the brain and usually restores the physiological balance between CSF production, flow, and absorption when one or more of these functions has been impaired. Valves contained within the shunt pathway act like on-off switches, opening when the differential pressure (DP) – i.e., the pressure difference across the valve – exceeds the valve’s opening pressure. Valves are either set to a fixed pressure or they can be adjustable from outside the body. Accessory devices may be added to the shunt to modify valve function.
The global Ventriculoperitoneal (VP) Shunt market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ventriculoperitoneal (VP) Shunt in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Care centers, Laboratories and Others, are propelling Ventriculoperitoneal (VP) Shunt market. Fixed Pressure Valves, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Variable Pressure Valves segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Ventriculoperitoneal (VP) Shunt market, driven by demand from China, the second largest economy with some signs of stabilising, the Ventriculoperitoneal (VP) Shunt market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ventriculoperitoneal (VP) Shunt, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ventriculoperitoneal (VP) Shunt market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ventriculoperitoneal (VP) Shunt market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ventriculoperitoneal (VP) Shunt sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ventriculoperitoneal (VP) Shunt covered in this report include Sophysa, Aesculap, B. Braun Melsungen, Integra lifesciences and Medtronic, etc.
The global Ventriculoperitoneal (VP) Shunt market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sophysa
Aesculap
B. Braun Melsungen
Integra lifesciences
Medtronic
Global Ventriculoperitoneal (VP) Shunt market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ventriculoperitoneal (VP) Shunt market, Segment by Type:
Fixed Pressure Valves
Variable Pressure Valves
Global Ventriculoperitoneal (VP) Shunt market, by Application
Hospitals
Clinics and Ambulatory Care centers
Laboratories
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ventriculoperitoneal (VP) Shunt manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ventriculoperitoneal (VP) Shunt in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
An implanted shunt diverts CSF from the ventricles within the brain or the subarachnoid spaces around the brain and spinal cord to another body region where it will be absorbed. This creates an alternative route for removal of CSF which is constantly produced within the brain and usually restores the physiological balance between CSF production, flow, and absorption when one or more of these functions has been impaired. Valves contained within the shunt pathway act like on-off switches, opening when the differential pressure (DP) – i.e., the pressure difference across the valve – exceeds the valve’s opening pressure. Valves are either set to a fixed pressure or they can be adjustable from outside the body. Accessory devices may be added to the shunt to modify valve function.
The global Ventriculoperitoneal (VP) Shunt market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ventriculoperitoneal (VP) Shunt in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Care centers, Laboratories and Others, are propelling Ventriculoperitoneal (VP) Shunt market. Fixed Pressure Valves, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Variable Pressure Valves segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Ventriculoperitoneal (VP) Shunt market, driven by demand from China, the second largest economy with some signs of stabilising, the Ventriculoperitoneal (VP) Shunt market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ventriculoperitoneal (VP) Shunt, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ventriculoperitoneal (VP) Shunt market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ventriculoperitoneal (VP) Shunt market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ventriculoperitoneal (VP) Shunt sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ventriculoperitoneal (VP) Shunt covered in this report include Sophysa, Aesculap, B. Braun Melsungen, Integra lifesciences and Medtronic, etc.
The global Ventriculoperitoneal (VP) Shunt market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sophysa
Aesculap
B. Braun Melsungen
Integra lifesciences
Medtronic
Global Ventriculoperitoneal (VP) Shunt market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ventriculoperitoneal (VP) Shunt market, Segment by Type:
Fixed Pressure Valves
Variable Pressure Valves
Global Ventriculoperitoneal (VP) Shunt market, by Application
Hospitals
Clinics and Ambulatory Care centers
Laboratories
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ventriculoperitoneal (VP) Shunt manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ventriculoperitoneal (VP) Shunt in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Ventriculoperitoneal (VP) Shunt Market Overview
1.1 Ventriculoperitoneal (VP) Shunt Product Overview
1.2 Ventriculoperitoneal (VP) Shunt Market Segment by Type
1.2.1 Fixed Pressure Valves
1.2.2 Variable Pressure Valves
1.3 Global Ventriculoperitoneal (VP) Shunt Market Size by Type
1.3.1 Global Ventriculoperitoneal (VP) Shunt Market Size Overview by Type (2018-2029)
1.3.2 Global Ventriculoperitoneal (VP) Shunt Historic Market Size Review by Type (2018-2023)
1.3.3 Global Ventriculoperitoneal (VP) Shunt Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ventriculoperitoneal (VP) Shunt Sales Breakdown by Type (2018-2023)
1.4.2 Europe Ventriculoperitoneal (VP) Shunt Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Ventriculoperitoneal (VP) Shunt Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Ventriculoperitoneal (VP) Shunt Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales Breakdown by Type (2018-2023)
2 Global Ventriculoperitoneal (VP) Shunt Market Competition by Company
2.1 Global Top Players by Ventriculoperitoneal (VP) Shunt Sales (2018-2023)
2.2 Global Top Players by Ventriculoperitoneal (VP) Shunt Revenue (2018-2023)
2.3 Global Top Players by Ventriculoperitoneal (VP) Shunt Price (2018-2023)
2.4 Global Top Manufacturers Ventriculoperitoneal (VP) Shunt Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ventriculoperitoneal (VP) Shunt Market Competitive Situation and Trends
2.5.1 Ventriculoperitoneal (VP) Shunt Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Ventriculoperitoneal (VP) Shunt Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ventriculoperitoneal (VP) Shunt as of 2022)
2.7 Date of Key Manufacturers Enter into Ventriculoperitoneal (VP) Shunt Market
2.8 Key Manufacturers Ventriculoperitoneal (VP) Shunt Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ventriculoperitoneal (VP) Shunt Status and Outlook by Region
3.1 Global Ventriculoperitoneal (VP) Shunt Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Ventriculoperitoneal (VP) Shunt Historic Market Size by Region
3.2.1 Global Ventriculoperitoneal (VP) Shunt Sales in Volume by Region (2018-2023)
3.2.2 Global Ventriculoperitoneal (VP) Shunt Sales in Value by Region (2018-2023)
3.2.3 Global Ventriculoperitoneal (VP) Shunt Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Ventriculoperitoneal (VP) Shunt Forecasted Market Size by Region
3.3.1 Global Ventriculoperitoneal (VP) Shunt Sales in Volume by Region (2024-2029)
3.3.2 Global Ventriculoperitoneal (VP) Shunt Sales in Value by Region (2024-2029)
3.3.3 Global Ventriculoperitoneal (VP) Shunt Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Ventriculoperitoneal (VP) Shunt by Application
4.1 Ventriculoperitoneal (VP) Shunt Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics and Ambulatory Care centers
4.1.3 Laboratories
4.1.4 Others
4.2 Global Ventriculoperitoneal (VP) Shunt Market Size by Application
4.2.1 Global Ventriculoperitoneal (VP) Shunt Market Size Overview by Application (2018-2029)
4.2.2 Global Ventriculoperitoneal (VP) Shunt Historic Market Size Review by Application (2018-2023)
4.2.3 Global Ventriculoperitoneal (VP) Shunt Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ventriculoperitoneal (VP) Shunt Sales Breakdown by Application (2018-2023)
4.3.2 Europe Ventriculoperitoneal (VP) Shunt Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Ventriculoperitoneal (VP) Shunt Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Ventriculoperitoneal (VP) Shunt Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales Breakdown by Application (2018-2023)
5 North America Ventriculoperitoneal (VP) Shunt by Country
5.1 North America Ventriculoperitoneal (VP) Shunt Historic Market Size by Country
5.1.1 North America Ventriculoperitoneal (VP) Shunt Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Ventriculoperitoneal (VP) Shunt Sales in Volume by Country (2018-2023)
5.1.3 North America Ventriculoperitoneal (VP) Shunt Sales in Value by Country (2018-2023)
5.2 North America Ventriculoperitoneal (VP) Shunt Forecasted Market Size by Country
5.2.1 North America Ventriculoperitoneal (VP) Shunt Sales in Volume by Country (2024-2029)
5.2.2 North America Ventriculoperitoneal (VP) Shunt Sales in Value by Country (2024-2029)
6 Europe Ventriculoperitoneal (VP) Shunt by Country
6.1 Europe Ventriculoperitoneal (VP) Shunt Historic Market Size by Country
6.1.1 Europe Ventriculoperitoneal (VP) Shunt Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Ventriculoperitoneal (VP) Shunt Sales in Volume by Country (2018-2023)
6.1.3 Europe Ventriculoperitoneal (VP) Shunt Sales in Value by Country (2018-2023)
6.2 Europe Ventriculoperitoneal (VP) Shunt Forecasted Market Size by Country
6.2.1 Europe Ventriculoperitoneal (VP) Shunt Sales in Volume by Country (2024-2029)
6.2.2 Europe Ventriculoperitoneal (VP) Shunt Sales in Value by Country (2024-2029)
7 Asia-Pacific Ventriculoperitoneal (VP) Shunt by Region
7.1 Asia-Pacific Ventriculoperitoneal (VP) Shunt Historic Market Size by Region
7.1.1 Asia-Pacific Ventriculoperitoneal (VP) Shunt Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Ventriculoperitoneal (VP) Shunt Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Ventriculoperitoneal (VP) Shunt Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Ventriculoperitoneal (VP) Shunt Forecasted Market Size by Region
7.2.1 Asia-Pacific Ventriculoperitoneal (VP) Shunt Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Ventriculoperitoneal (VP) Shunt Sales in Value by Region (2024-2029)
8 Latin America Ventriculoperitoneal (VP) Shunt by Country
8.1 Latin America Ventriculoperitoneal (VP) Shunt Historic Market Size by Country
8.1.1 Latin America Ventriculoperitoneal (VP) Shunt Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Ventriculoperitoneal (VP) Shunt Sales in Volume by Country (2018-2023)
8.1.3 Latin America Ventriculoperitoneal (VP) Shunt Sales in Value by Country (2018-2023)
8.2 Latin America Ventriculoperitoneal (VP) Shunt Forecasted Market Size by Country
8.2.1 Latin America Ventriculoperitoneal (VP) Shunt Sales in Volume by Country (2024-2029)
8.2.2 Latin America Ventriculoperitoneal (VP) Shunt Sales in Value by Country (2024-2029)
9 Middle East and Africa Ventriculoperitoneal (VP) Shunt by Country
9.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt Historic Market Size by Country
9.1.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt Forecasted Market Size by Country
9.2.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sophysa
10.1.1 Sophysa Company Information
10.1.2 Sophysa Introduction and Business Overview
10.1.3 Sophysa Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sophysa Ventriculoperitoneal (VP) Shunt Products Offered
10.1.5 Sophysa Recent Development
10.2 Aesculap
10.2.1 Aesculap Company Information
10.2.2 Aesculap Introduction and Business Overview
10.2.3 Aesculap Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Aesculap Ventriculoperitoneal (VP) Shunt Products Offered
10.2.5 Aesculap Recent Development
10.3 B. Braun Melsungen
10.3.1 B. Braun Melsungen Company Information
10.3.2 B. Braun Melsungen Introduction and Business Overview
10.3.3 B. Braun Melsungen Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2018-2023)
10.3.4 B. Braun Melsungen Ventriculoperitoneal (VP) Shunt Products Offered
10.3.5 B. Braun Melsungen Recent Development
10.4 Integra lifesciences
10.4.1 Integra lifesciences Company Information
10.4.2 Integra lifesciences Introduction and Business Overview
10.4.3 Integra lifesciences Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Integra lifesciences Ventriculoperitoneal (VP) Shunt Products Offered
10.4.5 Integra lifesciences Recent Development
10.5 Medtronic
10.5.1 Medtronic Company Information
10.5.2 Medtronic Introduction and Business Overview
10.5.3 Medtronic Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Medtronic Ventriculoperitoneal (VP) Shunt Products Offered
10.5.5 Medtronic Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ventriculoperitoneal (VP) Shunt Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ventriculoperitoneal (VP) Shunt Industrial Chain Analysis
11.4 Ventriculoperitoneal (VP) Shunt Market Dynamics
11.4.1 Ventriculoperitoneal (VP) Shunt Industry Trends
11.4.2 Ventriculoperitoneal (VP) Shunt Market Drivers
11.4.3 Ventriculoperitoneal (VP) Shunt Market Challenges
11.4.4 Ventriculoperitoneal (VP) Shunt Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ventriculoperitoneal (VP) Shunt Distributors
12.3 Ventriculoperitoneal (VP) Shunt Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
